Literature DB >> 33873153

Water-Based Interventions for People With Neurological Disability, Autism, and Intellectual Disability: A Scoping Review.

Karlee Naumann1, Jocelyn Kernot1, Gaynor Parfitt1, Bethany Gower1, Kade Davison1.   

Abstract

The purpose of this study was to produce a descriptive overview of the types of water-based interventions for people with neurological disability, autism, and intellectual disability and to determine how outcomes have been evaluated. Literature was searched through MEDLINE, EMBASE, Ovid Emcare, SPORTDiscus, Google Scholar, and Google. One hundred fifty-three papers met the inclusion criteria, 115 hydrotherapy, 62 swimming, 18 SCUBA (self-contained underwater breathing apparatus), and 18 other water-based interventions. Common conditions included cerebral palsy, spinal cord injury, Parkinson's disease, and intellectual disability. Fifty-four papers explored physical outcomes, 36 psychosocial outcomes, and 24 both physical and psychosocial outcomes, with 180 different outcome measures reported. Overall, there is a lack of high-quality evidence for all intervention types. This review provides a broad picture of water-based interventions and associated research. Future research, guided by this scoping review, will allow a greater understanding of the potential benefits for people with neurological disability, autism, and intellectual disability.

Entities:  

Keywords:  SCUBA; aquatic therapy; physical disabilities; physical therapy; rehabilitation; swimming

Mesh:

Substances:

Year:  2021        PMID: 33873153     DOI: 10.1123/apaq.2020-0036

Source DB:  PubMed          Journal:  Adapt Phys Activ Q        ISSN: 0736-5829            Impact factor:   2.741


  1 in total

Review 1.  What are the effects of scuba diving-based interventions for clients with neurological disability, autism or intellectual disability? A systematic review.

Authors:  Karlee Naumann; Jocelyn Kernot; Gaynor Parfitt; Bethayn Gower; Adrian Winsor; Kade Davison
Journal:  Diving Hyperb Med       Date:  2021-12-20       Impact factor: 0.887

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.